-
A POPULATION-BASED DATA LINKAGE APPROACH TO STUDY FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA: OVERCOMING DATA FRAGMENTATION
Aug 11, 2026, 17:16 PM -
COST-EFFECTIVENESS OF MALARIA PREVENTION STRATEGIES IN CHILDREN UNDER FIVE IN HIGH-ENDEMIC SETTINGS
Aug 11, 2026, 17:16 PM -
CHRONIC KIDNEY DISEASE PREVENTION INVESTMENT BY STAGE: WHERE SCREENING SAVES THE MOST AND WHY
Aug 11, 2026, 17:16 PM -
REAL-WORLD EVIDENCE ON ORAL CLADRIBINE IN MULTIPLE SCLEROSIS: CLINICAL EFFECTIVENESS, TREATMENT PATTERNS AND ECONOMIC BURDEN
Aug 11, 2026, 17:16 PM -
HTA METHODOLOGICAL ADAPTATIONS FOR RARE DISEASES AND ORPHAN DRUGS: A REVIEW OF GLOBAL FRAMEWORKS AND CONSIDERATIONS FOR LATIN AMERICA
Aug 11, 2026, 17:16 PM -
A HYBRID AI-ASSISTED SCREENING FRAMEWORK FOR SYSTEMATIC LITERATURE REVIEWS IN ACUTE ISCHAEMIC STROKE-LARGE VESSEL OCCLUSION: EFFICIENCY AND ACCURACY
Aug 11, 2026, 17:16 PM -
GOVERNMENT AND COMPULSORY HEALTH FINANCING AND HOUSEHOLD OUT-OF-POCKET PAYMENT IN CENTRAL AND EASTERN EUROPE: A COMPARATIVE ANALYSIS, 2014-2023
Aug 11, 2026, 17:16 PM -
DEVELOPMENT OF AN ONLINE EVIDENCE GENERATION SUPPORT TOOL FOR DIGITAL HEALTH TECHNOLOGY DEVELOPERS: PRELIMINARY RESULTS FROM THE ASSESS DHT PROJECT
Aug 11, 2026, 17:16 PM -
HEALTH-RELATED QUALITY OF LIFE BURDEN ASSOCIATED WITH PAST-YEAR DEPRESSION IN THE EU5: A MATCHED NATIONAL HEALTH AND WELLNESS SURVEY ANALYSIS
Aug 11, 2026, 17:16 PM -
AUTOMATED TECHNICAL VERIFICATION OF HEALTH ECONOMIC MODELS USING A GENERATIVE-AI AGENT: CONCORDANCE WITH EXPERT REVIEW ACROSS SPREADSHEET AND PROGRAMMATIC IMPLEMENTATIONS
Aug 11, 2026, 17:16 PM -
CKM-KG: A UNIFIED CARDIOVASCULAR-KIDNEY-METABOLIC KNOWLEDGE GRAPH FOR EVIDENCE INTEGRATION, WITH HYPERTENSION AS A CASE STUDY
Aug 11, 2026, 17:16 PM -
COST-EFFECTIVENESS OF THE TWENTY-VALENT PNEUMOCOCCAL CONJUGATE VACCINE AGAINST CURRENTLY AVAILABLE LOWER-VALENT PNEUMOCOCCAL CONJUGATE VACCINES IN INDIAN CHILDREN FROM THE PRIVATE PAYER PERSPECTIVE
Aug 11, 2026, 17:16 PM -
REGULATORY/HTA FRAMING PATIENT-REPORTED OUTCOME INSTRUMENTS IN ULCERATIVE COLITIS CLINICAL TRIALS: FREQUENCY OF USE AND PSYCHOMETRIC EVIDENCE
Aug 11, 2026, 17:16 PM -
TREATMENT BURDEN AND ECONOMIC IMPACT OF SWITCHING TO FARICIMAB IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: A REAL-WORLD STUDY IN PORTUGAL
Aug 11, 2026, 17:16 PM -
UTILITY GENERATION FOR SANFILIPPO SYNDROME TYPE A (MPS IIIA) USING HEALTH-STATE VIGNETTES
Aug 11, 2026, 17:16 PM -
METABOLOMIC SIGNATURES AND THERAPEUTIC DRUG MONITORING IN SCHIZOPHRENIA: A SCOPING REVIEW OF ANTIPSYCHOTIC TREATMENT OUTCOMES
Aug 11, 2026, 17:16 PM -
HOW DO REGULATORY AND HTA BODIES ADDRESS CLINICAL TRIAL REPRESENTATIVENESS AND INCLUSIVITY: A GREY LITERATURE REVIEW FROM READI
Aug 11, 2026, 17:16 PM -
ASSESSING COST SAVINGS FROM FIRST GENERIC ENTRY IN SAUDI ARABIA: A REAL-WORLD BUDGET IMPACT ANALYSIS (2021-2024)
Aug 11, 2026, 17:16 PM -
COST-EFFECTIVENESS OF PAFOLACIANINE-GUIDED INTRAOPERATIVE MOLECULAR IMAGING WITH STANDARD OF CARE VERSUS STANDARD OF CARE ALONE FOR THE IDENTIFICATION OF OCCULT SYNCHRONOUS LESIONS DURING LUNG CANCER SURGICAL RESECTIONS IN US
Aug 11, 2026, 17:16 PM -
PREFERENCE ELICITATION USING TTO AND DCE: WHO FINDS WHICH TASKS MORE DIFFICULT?
Aug 11, 2026, 17:16 PM
